Litcius/Paper detail

Efficacy and safety of trastuzumab deruxtecan in treating human epidermal growth factor receptor 2-low/positive advanced breast cancer:A meta-analysis of randomized controlled trials

Rui Ma, Yixun Shi, Ruijuan Yan, Shiqing Yin, H. Bu, Jie Huang

2024Critical Reviews in Oncology/Hematology10 citationsDOI

Topics & Concepts

TrastuzumabMedicineInternal medicineOncologyBreast cancerAdverse effectCochrane LibraryClinical trialRandomized controlled trialCancerMeta-analysisHER2/EGFR in Cancer ResearchBreast Cancer Treatment StudiesBreast Lesions and Carcinomas
Efficacy and safety of trastuzumab deruxtecan in treating human epidermal growth factor receptor 2-low/positive advanced breast cancer:A meta-analysis of randomized controlled trials | Litcius